Although one study reported that women who possess specific rare pathological ATM missense variants and who receive therapeutic radiation may have an elevated risk for developing contralateral breast cancer [63], this precaution will not apply to the majority of carriers who develop breast or any other cancer. The gene discussed is ATM; the disease is breast carcinoma.